EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy

Zhuoyi Zhang, Yalin Huang, Yumin Ye, Zhenhua Wang

Frontiers in Cardiovascular Medicine · 04.05.2026 · 13

DOI: 10.3389/fcvm.2026.1780572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 04.05.2026. Verfasst von Zhuoyi Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In-stent restenosis (ISR) is a serious complication that occurs after a percutaneous coronary intervention (PCI). This study aims to integrate thromboelastography (TEG) parameters, coagulation function, and clinical indicators to develop and validate a prediction model for ISR during antiplatelet therapy after PCI.

Method

A total of 401 consecutive patients with coronary artery disease who underwent a PCI with drug-eluting stent implantation between January 2018 and January 2024 were enrolled in this study. Clinical baseline characteristics were collected. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to screen 6 key predictors from 34 candidate clinical features. Multivariate logistic regression identified independent risk factors for ISR. Model performance was evaluated using the receiver operating characteristic curve for discrimination, bootstrap internal validation for stability, the Hosmer–Lemeshow test for goodness of fit, and decision curve analysis for clinical utility.

Results

Among the 401 enrolled patients, 137 (34.2%) developed ISR. LASSO regression selected 6 key predictors from 34 candidate variables. Multivariable logistic regression ultimately identified a low adenosine diphosphate (ADP) inhibition rate, a low arachidonic acid (AA) inhibition rate, reaction time ( R -value), and age as independent risk factors for ISR. The constructed nomogram demonstrated good discrimination (area under the curve = 0.752, 95% confidence interval: 0.702–0.803), stable performance upon bootstrap internal validation, and satisfactory calibration (Hosmer–Lemeshow test, P = 0.320). Furthermore, decision curve analysis indicated a favorable clinical net benefit across a broad range of threshold probabilities.

Conclusions

The prediction model, constructed based on TEG parameters (ADP inhibition rate, AA inhibition rate, R -value), age, and N-terminal pro-B-type natriuretic peptide, effectively identifies patients at high risk for ISR after a PCI. It provides a basis for individualized antiplatelet therapy and postoperative management decisions.

Schlagwörter

Stichwörter der Autor:innen

antiplatelet therapycoronary heart disease (CHD)in-stent restenosis (ISR)nomogrampercutaneous coronary intervention (PCI)thromboelastography (TEG)

Autor:innen und Institutionen

  • Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

Zitieren

APA

Zhang, Z., Huang, Y., Ye, Y., & Wang, Z. (2026). Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1780572

Vancouver

Zhang Z, Huang Y, Ye Y, Wang Z. Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1780572

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhuoyi and Huang, Yalin and Ye, Yumin and Wang, Zhenhua},
  title = {Construction and validation of a prediction model for in-stent restenosis following coronary stent implantation during dual antiplatelet therapy},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1780572}
}
Kostenlos starten →